Canadian (TSX) Groei aandelen Pharmaceuticals & Biotech

Name: Financiële inzichten gebaseerd op S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Mar 14, 2026

Ontdek Canadian Pharmaceuticals & Biotech Groeiaandelen die op de TSX. Gesorteerd op voorspelde groei, hebben deze Pharmaceuticals & Biotech Stocks een hoger dan verwachte winst- of omzetgroei in vergelijking met andere bedrijven.

149 bedrijven

Bedrijf	Laatste prijs	7D Terugkeer	1 J Rendement	Marktkapitalisatie	Doel analisten	Waardering	Groei	Div Opbrengst
DHB	CA$0.17	6.3%	21.4%	CA$5.3m	n/a	1.4	150.4%	n/a
XRTX	CA$0.51	-15.0%	-64.6%	CA$3.6m	n/a	1.2	150.1%	n/a
VRNO	CA$1.51	-13.7%	58.9%	CA$548.5m	CA$4.70	0.6	128.1%	n/a
TRUL	CA$8.78	-3.5%	45.6%	CA$1.7b	CA$19.72	1.0	112.2%	n/a
HITI	CA$3.40	1.5%	-2.3%	CA$298.7m	CA$7.50	3.4	111.0%	n/a
CRON	CA$3.44	-2.0%	27.4%	CA$1.3b	CA$4.24	6.5	94.4%	n/a
ACB	CA$4.70	-1.7%	-25.9%	CA$266.5m	CA$7.62	0.5	90.8%	n/a
LABS	CA$0.065	0%	-27.8%	CA$27.6m	n/a	0.7	86.2%	n/a
PLTH	CA$0.21	-8.5%	-51.1%	CA$70.6m	n/a	0.9	85.8%	n/a
CL	CA$1.34	-2.9%	25.2%	CA$601.9m	CA$2.30	1.0	84.2%	n/a
VEXT	CA$0.26	6.1%	57.6%	CA$65.3m	n/a	0.7	81.1%	n/a
WEED	CA$1.41	-3.4%	-10.2%	CA$532.8m	CA$2.46	1.9	66.5%	n/a
HLS	CA$4.40	0.9%	10.0%	CA$137.6m	CA$7.84	1.8	65.8%	0%
EDT	CA$1.29	-1.5%	87.0%	CA$377.4m	CA$3.10	139.5	65.7%	n/a
SVA	CA$0.17	6.3%	-2.9%	CA$58.0m	n/a	-4.7	64.3%	n/a
NGEN	CA$5.00	-8.4%	83.8%	CA$398.2m	CA$7.48	-15.6	63.8%	n/a
MDP	CA$3.14	1.3%	23.6%	CA$101.2m	CA$6.87	1.4	59.6%	n/a
CRDL	CA$1.41	8.5%	-13.5%	CA$156.4m	CA$6.00	16.4	59.0%	n/a
CURA	CA$3.23	0.3%	141.0%	CA$2.5b	CA$4.90	1.4	56.0%	n/a
GUD	CA$6.10	-1.0%	1.8%	CA$598.0m	CA$7.93	1.4	54.0%	n/a
COV	CA$1.76	-5.4%	-24.5%	CA$48.6m	CA$2.90	49.7	28.9%	8.5%
DB	CA$0.12	0%	71.4%	CA$69.2m	n/a	5.9	19.2%	n/a
MSCL	CA$10.98	-32.2%	-0.5%	CA$226.5m	CA$15.32	4.9	13.8%	n/a
EPRX	CA$10.15	-7.0%	70.0%	CA$610.2m	CA$15.33	8.5	13.2%	n/a

Page 1 of 7